Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 65 Pharmacy (pharmaceutical sciences) PhD Projects, Programmes & Scholarships for Self-funded Students

Discipline

Discipline

Medicine

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a self funded student


Pharmacy (pharmaceutical sciences) PhD Projects, Programmes & Scholarships for Self-funded Students

We have 65 Pharmacy (pharmaceutical sciences) PhD Projects, Programmes & Scholarships for Self-funded Students

Peptide-mediated nanocarrier drug delivery for enhanced brain targeting and treatment of inflammation

This project involves the study of nanoparticles and drug delivery to the brain. The student would be required to make and characterise novel nanoparticles from special lipid molecules of various compositions more suitable for blood-brain barrier (BBB) targeting. Read more

Understanding how formulation parameters influence the performance of novel capsule formulations

Two-piece capsules are used in dry powder inhalers (DPIs) as a single-dose container for powdered pharmaceutical formulations. These formulations contain active pharmaceutical ingredients to treat pulmonary conditions, such as asthma and chronic obstructive pulmonary disease. Read more

Discovery of Novel Cancer Immunotherapeutic Agents

Summary. Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality. Read more

Discovery of New Treatments for Parkinson’s disease

Summary. Parkinson’s disease (PD) is the second most common neurological disease in the world. Current PD therapies and medical interventions are very limited and only address the symptoms of this disease highlighting the need for new and effective treatments for this disease. Read more

Small molecule cancer drug discovery targeting resistant disease.

Despite continuous advances in targeted cancer therapy in recent years, there remains a major challenge to combat drug resistance and poor levels of efficacy in areas of unmet medical need, such as advanced colorectal and breast cancer. Read more
Last chance to apply

Preformulation study of RARγ and VDR hybrid compounds

The doctoral candidate (DC) will perform preformulation characterisation and development of formulation prototypes at Trinity College Dublin (TCD), Ireland. Read more

Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more

Microfluidic technologies applied to respiratory diseases

Subject area. 3D Printing, lab-on-a-chip, Drug Delivery, Pharmaceutical Technology. In Preclinical studies, a large number of molecules and biomolecules, in a very short time, have to be evaluated in terms of efficacy and toxicity. Read more

Microneedle delivery systems for minimally-invasive patient diagnosis/monitoring

In this project, a novel type of integrated system will be investigated that will by-pass the skin barrier. On its surface will be multiple microscopic needles that pierce the skin without causing any pain – the sensation is said to feel like a cat’s tongue or sharkskin. Read more

Structure-based design of allosteric modulators for G protein-coupled receptors using molecular modelling and pharmacology experiments

Almost all physiological processes are regulated through the activation of G protein-coupled receptors (GPCRs). It has become widely accepted that most GPCRs possess binding sites spatially distinct from their natural ligand binding site (orthosteric site), termed as allosteric sites. Read more

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

One in two people will develop cancer in their lifetime and it is a leading cause of death.  While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. . Read more

Enzyme-responsive peptide hydrogels as in situ forming long-acting drug delivery implants

One of the key issues in the treatment and prevention of disease is that patients struggle to adhere to the complex dosage regimens of therapies, which often require multiple dosing at very specific times each day. Read more

Filtering Results